GM
Garrido, M.
3 papers · 244 citations · 2023–2025
Publications
3
Citations
244
Years
2
Publications
| Title | Year | Type | Citations |
|---|---|---|---|
|
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
|
2025 | Article | 161 |
|
Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Interim results of the global, phase III MATTERHORN study
|
2023 | Meeting Abstract | 11 |
|
Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Interim results of the global, phase III MATTERHORN study
|
2023 | Meeting Abstract | 72 |